Metabolism and accumulation of the lipophilic deoxynucleoside analogs elacytarabine and CP-4126.

Metabolism and accumulation of the lipophilic deoxynucleoside analogs elacytarabine and CP-4126.
复制标题

DOI:
10.1007/s10637-011-9756-8
复制
发表时间:
2012-10
影响因子:
3.4
通讯作者:
Peters, Godefridus J.
Peters, Godefridus J.
中科院分区:
医学3区
文献类型:
--
作者:
Adema, Auke D.;Smid, Kees;Losekoot, Nienke;Honeywell, Richard J.;Verheul, Henk M.;Myhren, Finn;Sandvold, Marit L.;Peters, Godefridus J.

文献摘要

参考文献

被引文献

相似文献

Cytarabine (ara-C) and gemcitabine (dFdC) are commonly used anticancer drugs, which depend on the equilibrative (ENT) and concentrative-nucleoside-transporters to enter the cell. To bypass transport-related drug resistance, lipophilic derivatives elacytarabine (CP-4055), ara-C-5′elaidic-acid-ester, and CP-4126, (CO 1.01) gemcitabine-5′elaidic-acid-ester, were investigated for the entry into the cell, distribution, metabolism and retention. The leukemic CEM-cell-line and its deoxycytidine-kinase deficient variant (CEM/dCK-) were exposed for 30 and 60 min to the radiolabeled drugs; followed by culture in drug-free medium in order to determine drug retention in the cell. The cellular fractions were analyzed with thin-layer-chromatography and HPLC. Elacytarabine and CP-4126 were converted to the parent compounds both inside and outside the cell (35–45%). The ENT-inhibitor dipyridamole did not affect their uptake or retention. Inside the cell Elacytarabine and CP-4126 predominantly localized in the membrane and cytosolic fraction, leading to a long retention after removal of the medium. In contrast, in cells exposed to the parent drugs ara-C and dFdC, intracellular drug concentration increased during exposure but decreased to undetectable levels after drug removal. In the dCK- cell line, no metabolism was observed. The concentrations of ara-CTP and dFdCTP reached a peak at the end of the incubation with the drugs, and decreased after drug removal; peak levels of dFdCTP were 35 times higher than ara-CTP and was retained better. In contrast, after exposure to elacytarabine or CP-4126, ara-CTP and dFdCTP levels continued to increase not only during exposure but also during 120 min after removal of the elacytarabine and CP-4126. Levels of ara-CTP and dFdCTP were higher than after exposure to the parent drugs. In conclusion, the lipophilic derivatives elacytarabine and CP-4126 showed a nucleoside-transporter independent uptake, with long retention of the active nucleotides. These lipophilic nucleoside analogues are new chemical entities suitable for novel clinical applications.
DOI: 10.1007/s10637-009-9377-7
发表时间: 2011-06
影响因子: 3.4
作者:
Bergman, Andries M.;Adema, Auke D.;Balzarini, Jan;Bruheim, Skjalg;Fichtner, Iduna;Noordhuis, Paul;Fodstad, Oystein;Myhren, Finn;Sandvold, Marit L.;Hendriks, Hans R.;Peters, Godefridus J.
通讯作者: Peters, Godefridus J.
DOI: 10.1634/theoncologist.13-s1-5
发表时间: 2008-01-01
期刊: ONCOLOGIST
影响因子: 5.8
作者:
Ramalingam, Suresh;Belani, Chandra
通讯作者: Belani, Chandra
DOI: 10.3892/ijo_00000499
发表时间: 2010-01-01
影响因子: 5.2
作者:
Adema, A. D.;Laan, A. C.;Peters, G. J.
通讯作者: Peters, G. J.
DOI: 10.1081/ncn-200027579
发表时间: 2004-10-01
影响因子: 1.3
作者:
Bergman, AM;Kuiper, CM;Peters, GJ
通讯作者: Peters, GJ
DOI: 10.1016/0145-2126(95)00071-2
发表时间: 1996-02-01
期刊: LEUKEMIA RESEARCH
影响因子: 2.7
作者:
Noordhuis, P;Kazemier, KM;Peters, GJ
通讯作者: Peters, GJ